BIORESTORATIVE THERAPIES, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
BIORESTORATIVE THERAPIES, INC. (BRTX) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.76 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2021-11-15
- BIORESTORATIVE THERAPIES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2021-09-30 was $1.76M, a 853.82% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2021-06-30 was $1.76M, a 703.75% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2021-03-31 was $13.90M, a 6163.57% increase year-over-year.
- BIORESTORATIVE THERAPIES, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2020-09-30 was $184.77K, a 21.06% decline year-over-year.
- BIORESTORATIVE THERAPIES, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2020 was $691.70K, a 57.53% decline from fiscal 2019.
- BIORESTORATIVE THERAPIES, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2019 was $1.63M, a 25.24% decline from fiscal 2018.
- BIORESTORATIVE THERAPIES, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2018 was $2.18M, a 39.17% decline from fiscal 2017.
- BIORESTORATIVE THERAPIES, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2017 was $3.58M, a 46.95% increase from fiscal 2016.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|
| 2021-09-30 | $1.76M 10-Q · filed 2021-11-15 | $3.52M derived: sum of 2 quarters · filed 2021-11-15 | $17.42M derived: sum of 3 quarters · filed 2021-11-15 | ||
| 2021-06-30 | $1.76M 10-Q · filed 2021-11-15 | $15.66M derived: sum of 2 quarters · filed 2021-11-15 | |||
| 2021-03-31 | $13.90M 10-Q · filed 2021-11-15 | ||||
| 2020-12-31 | $691.70K 10-K · filed 2021-04-30 | ||||
| 2020-09-30 | $184.77K 10-Q · filed 2021-11-15 | $404.03K derived: sum of 2 quarters · filed 2021-11-15 | $625.91K derived: sum of 3 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $219.26K 10-Q · filed 2021-11-15 | $441.14K derived: sum of 2 quarters · filed 2021-11-15 | |||
| 2020-03-31 | $221.88K 10-Q · filed 2021-11-15 | ||||
| 2019-12-31 | $1.63M 10-K · filed 2021-04-30 | ||||
| 2019-09-30 | $234.04K 10-Q · filed 2021-04-12 | $676.85K derived: sum of 2 quarters · filed 2021-04-12 | $1.41M derived: sum of 3 quarters · filed 2021-04-12 | $2.09M derived: sum of 4 quarters · filed 2021-04-12 | |
| 2019-06-30 | $442.80K 10-Q · filed 2021-04-12 | $1.17M derived: sum of 2 quarters · filed 2021-04-12 | $1.86M derived: sum of 3 quarters · filed 2021-04-12 | $1.64M derived: sum of 4 quarters · filed 2021-04-12 | |
| 2019-03-31 | $729.68K 10-Q · filed 2021-04-12 | $1.42M derived: sum of 2 quarters · filed 2021-04-12 | $1.20M derived: sum of 3 quarters · filed 2021-04-12 | $2.03M derived: sum of 4 quarters · filed 2021-04-12 | |
| 2018-12-31 | $687.21K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $468.36K derived: sum of 2 quarters · filed 2021-03-18 | $1.30M derived: sum of 3 quarters · filed 2021-03-18 | $2.18M 10-K · filed 2021-03-18 | |
| 2018-09-30 | -$218.85K 10-Q · filed 2019-11-13 | $608.33K derived: sum of 2 quarters · filed 2019-11-13 | $1.49M 10-Q · filed 2019-11-13 | $2.01M derived: sum of 4 quarters · filed 2019-11-13 | |
| 2018-06-30 | $827.19K 10-Q · filed 2019-08-14 | $1.71M 10-Q · filed 2018-08-14 | $2.23M derived: sum of 3 quarters · filed 2019-08-14 | $3.01M derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $882.81K 10-Q · filed 2019-08-14 | $1.40M derived: sum of 2 quarters · filed 2019-08-14 | $2.18M derived: sum of 3 quarters · filed 2019-08-14 | $3.51M derived: sum of 4 quarters · filed 2019-08-14 | |
| 2017-12-31 | $516.05K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $1.30M derived: sum of 2 quarters · filed 2019-03-29 | $2.63M derived: sum of 3 quarters · filed 2019-03-29 | $3.58M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $781.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $2.11M derived: sum of 2 quarters · filed 2017-11-14 | $3.06M 10-Q · filed 2017-11-14 | $3.72M derived: sum of 4 quarters · filed 2018-04-02 | |
| 2017-06-30 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $2.28M 10-Q · filed 2017-08-14 | $2.94M derived: sum of 3 quarters · filed 2018-04-02 | ||
| 2017-03-31 | $955.39K 10-Q · filed 2017-05-15 | $1.61M derived: sum of 2 quarters · filed 2018-04-02 | |||
| 2016-12-31 | $655.54K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $2.44M 10-K · filed 2018-04-02 | |||
| 2016-09-30 | $1.78M 10-Q · filed 2016-11-14 | ||||
| 2016-03-31 | $360.99K 10-Q · filed 2016-05-13 | $7.49M derived: sum of 2 quarters · filed 2017-03-22 | $7.80M derived: sum of 3 quarters · filed 2017-03-22 | $7.99M derived: sum of 4 quarters · filed 2017-03-22 | |
| 2015-12-31 | $7.13M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $7.44M derived: sum of 2 quarters · filed 2017-03-22 | $7.63M derived: sum of 3 quarters · filed 2017-03-22 | $7.92M 10-K · filed 2017-03-22 | $1.78M 10-K · filed 2016-03-30 |
| 2015-09-30 | $310.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-23 | $500.13K derived: sum of 2 quarters · filed 2015-11-23 | $794.65K 10-Q · filed 2015-11-23 | $1.04M derived: sum of 4 quarters · filed 2016-03-30 | |
| 2015-06-30 | $190.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $484.53K 10-Q · filed 2015-08-14 | $727.93K derived: sum of 3 quarters · filed 2016-03-30 | $866.64K derived: sum of 4 quarters · filed 2016-03-30 | |
| 2015-03-31 | $294.52K 10-Q · filed 2015-05-15 | $537.92K derived: sum of 2 quarters · filed 2016-03-30 | $676.64K derived: sum of 3 quarters · filed 2016-03-30 | $994.60K derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-12-31 | $243.40K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $382.12K derived: sum of 2 quarters · filed 2016-03-30 | $700.08K derived: sum of 3 quarters · filed 2016-03-30 | $1.06M 10-K · filed 2016-03-30 | $1.06M 10-K · filed 2015-03-31 |
| 2014-09-30 | $138.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $456.68K derived: sum of 2 quarters · filed 2014-11-13 | $816.11K 10-Q · filed 2014-11-13 | $996.41K derived: sum of 4 quarters · filed 2015-03-31 | |
| 2014-06-30 | $317.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $677.39K 10-Q · filed 2014-08-14 | $857.70K derived: sum of 3 quarters · filed 2015-03-31 | $1.04M derived: sum of 4 quarters · filed 2015-03-31 | |
| 2014-03-31 | $359.43K 10-Q · filed 2014-05-14 | $539.73K derived: sum of 2 quarters · filed 2015-03-31 | $718.88K derived: sum of 3 quarters · filed 2015-03-31 | $827.21K derived: sum of 4 quarters · filed 2015-03-31 | |
| 2013-12-31 | $180.30K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $359.45K derived: sum of 2 quarters · filed 2015-03-31 | $467.79K derived: sum of 3 quarters · filed 2015-03-31 | $674.59K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $179.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | $287.48K derived: sum of 2 quarters · filed 2013-11-19 | $494.29K 10-Q · filed 2013-11-19 | $1.10M derived: sum of 4 quarters · filed 2014-04-11 | |
| 2013-06-30 | $108.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-19 | $315.14K 10-Q · filed 2013-08-19 | $921.52K derived: sum of 3 quarters · filed 2014-04-11 | $1.20M derived: sum of 4 quarters · filed 2014-04-11 | |
| 2013-03-31 | $206.81K 10-Q · filed 2013-05-15 | $813.18K derived: sum of 2 quarters · filed 2014-04-11 | $1.09M derived: sum of 3 quarters · filed 2014-04-11 | $1.39M derived: sum of 4 quarters · filed 2014-04-11 | |
| 2012-12-31 | $606.38K derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-11 | $882.84K derived: sum of 2 quarters · filed 2014-04-11 | $1.18M derived: sum of 3 quarters · filed 2014-04-11 | $1.64M 10-K · filed 2014-04-11 | |
| 2012-09-30 | $276.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $573.33K derived: sum of 2 quarters · filed 2012-11-05 | $1.04M 10-Q · filed 2012-11-05 | $1.05M derived: sum of 4 quarters · filed 2014-04-11 | |
| 2012-06-30 | $296.87K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-08-14 | $758.59K 10-Q · filed 2012-08-14 | $772.06K derived: sum of 3 quarters · filed 2014-04-11 | $777.53K derived: sum of 4 quarters · filed 2014-04-11 | |
| 2012-03-31 | $461.73K 10-Q/A · filed 2012-06-01 | $475.19K derived: sum of 2 quarters · filed 2014-04-11 | $480.66K derived: sum of 3 quarters · filed 2014-04-11 | ||
| 2011-12-31 | $13.47K derived: 10-K 12 month − 10-Q 9 month · filed 2014-04-11 | $18.94K derived: sum of 2 quarters · filed 2014-04-11 | $50.93K 10-K · filed 2014-04-11 | ||
| 2011-09-30 | $5.47K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | $37.46K 10-Q · filed 2011-11-21 | |||
| 2011-06-30 | $31.99K 10-Q/A · filed 2011-09-14 | ||||
| 2010-12-31 | $583.68K 10-K · filed 2014-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |